1h Free Analyst Time
The global tourettes syndrome drugs market is forecasted to grow by USD 739.6 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global tourettes syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in neurobiological research and targeted drug development, rising global awareness and enhanced diagnostic capabilities, favorable regulatory environments and financial incentives for orphan drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global tourettes syndrome drugs market is segmented as below:
By Product
- Antipsychotics
- Non-antipsychotics
By Distribution Channel
- Offline
- Online
By Application
- Children
- Adults
Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global tourettes syndrome drugs market covers the following areas:
- Global tourettes syndrome drugs market sizing
- Global tourettes syndrome drugs market forecast
- Global tourettes syndrome drugs market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Tourettes Syndrome Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Tourettes Syndrome Drugs Market
6.2 Impact of Geopolitical Conflicts on Global Tourettes Syndrome Drugs Market
6.2 Impact of Geopolitical Conflicts on Global Tourettes Syndrome Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product
8.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Antipsychotics - Market size and forecast 2025-2030 ($ million)
- Data Table on Antipsychotics - Market size and forecast 2025-2030 ($ million)
- Chart on Antipsychotics - Year-over-year growth 2025-2030 (%)
- Data Table on Antipsychotics - Year-over-year growth 2025-2030 (%)
- Chart on Non-antipsychotics - Market size and forecast 2025-2030 ($ million)
- Data Table on Non-antipsychotics - Market size and forecast 2025-2030 ($ million)
- Chart on Non-antipsychotics - Year-over-year growth 2025-2030 (%)
- Data Table on Non-antipsychotics - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Offline - Market size and forecast 2025-2030 ($ million)
- Data Table on Offline - Market size and forecast 2025-2030 ($ million)
- Chart on Offline - Year-over-year growth 2025-2030 (%)
- Data Table on Offline - Year-over-year growth 2025-2030 (%)
- Chart on Online - Market size and forecast 2025-2030 ($ million)
- Data Table on Online - Market size and forecast 2025-2030 ($ million)
- Chart on Online - Year-over-year growth 2025-2030 (%)
- Data Table on Online - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Application
10.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Children - Market size and forecast 2025-2030 ($ million)
- Data Table on Children - Market size and forecast 2025-2030 ($ million)
- Chart on Children - Year-over-year growth 2025-2030 (%)
- Data Table on Children - Year-over-year growth 2025-2030 (%)
- Chart on Adults - Market size and forecast 2025-2030 ($ million)
- Data Table on Adults - Market size and forecast 2025-2030 ($ million)
- Chart on Adults - Year-over-year growth 2025-2030 (%)
- Data Table on Adults - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Advancements in neurobiological research and targeted drug development
- Rising global awareness and enhanced diagnostic capabilities
- Favorable regulatory environments and financial incentives for orphan drugs
- Diagnostic ambiguity and pathophysiological complexity
- Regulatory constraints and clinical trial vulnerabilities
- Suboptimal safety profiles and patient non-adherence
- Impact of drivers and challenges in 2025 and 2030
- Evolution of non-dopaminergic pharmacological interventions
- Integration of digital therapeutics and wearable monitoring technologies
- Strategic focus on precision medicine and pharmacogenomic tailoring
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Bausch Health Co Inc. - Overview
- Bausch Health Co Inc. - Business segments
- Bausch Health Co Inc. - Key offerings
- Bausch Health Co Inc. - Segment focus
- SWOT
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- SWOT
- H. Lundbeck AS - Overview
- H. Lundbeck AS - Product / Service
- H. Lundbeck AS - Key offerings
- SWOT
- Ionis Pharmaceuticals Inc. - Overview
- Ionis Pharmaceuticals Inc. - Product / Service
- Ionis Pharmaceuticals Inc. - Key news
- Ionis Pharmaceuticals Inc. - Key offerings
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Kyowa Kirin Co. Ltd. - Overview
- Kyowa Kirin Co. Ltd. - Business segments
- Kyowa Kirin Co. Ltd. - Key offerings
- Kyowa Kirin Co. Ltd. - Segment focus
- SWOT
- Neurocrine Biosciences Inc. - Overview
- Neurocrine Biosciences Inc. - Product / Service
- Neurocrine Biosciences Inc. - Key offerings
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- Tasly Pharmaceutical Group Co. - Overview
- Tasly Pharmaceutical Group Co. - Product / Service
- Tasly Pharmaceutical Group Co. - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Product - Market share 2025-2030 (%)
Exhibit 39: Data Table on Product - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Product
Exhibit 41: Data Table on Comparison by Product
Exhibit 42: Chart on Antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Non-antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Non-antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Non-antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Non-antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 66: Chart on Application - Market share 2025-2030 (%)
Exhibit 67: Data Table on Application - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Application
Exhibit 69: Data Table on Comparison by Application
Exhibit 70: Chart on Children - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Children - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Children - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Children - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Adults - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Adults - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Adults - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Adults - Year-over-year growth 2025-2030 (%)
Exhibit 78: Market opportunity by Application ($ million)
Exhibit 79: Data Table on Market opportunity by Application ($ million)
Exhibit 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 81: Chart on Market share by geography 2025-2030 (%)
Exhibit 82: Data Table on Market share by geography 2025-2030 (%)
Exhibit 83: Chart on Geographic comparison
Exhibit 84: Data Table on Geographic comparison
Exhibit 85: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 88: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 89: Chart on Regional Comparison - North America
Exhibit 90: Data Table on Regional Comparison - North America
Exhibit 91: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 95: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Regional Comparison - Europe
Exhibit 108: Data Table on Regional Comparison - Europe
Exhibit 109: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Regional Comparison - Asia
Exhibit 138: Data Table on Regional Comparison - Asia
Exhibit 139: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 168: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 169: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Market opportunity by geography ($ million)
Exhibit 202: Data Tables on Market opportunity by geography ($ million)
Exhibit 203: Impact of drivers and challenges in 2025 and 2030
Exhibit 204: Overview on criticality of inputs and factors of differentiation
Exhibit 205: Overview on factors of disruption
Exhibit 206: Impact of key risks on business
Exhibit 207: Companies covered
Exhibit 208: Company ranking index
Exhibit 209: Matrix on companies position and classification
Exhibit 210: AstraZeneca Plc - Overview
Exhibit 211: AstraZeneca Plc - Business segments
Exhibit 212: AstraZeneca Plc - Key news
Exhibit 213: AstraZeneca Plc - Key offerings
Exhibit 214: AstraZeneca Plc - Segment focus
Exhibit 215: SWOT
Exhibit 216: Bausch Health Co Inc. - Overview
Exhibit 217: Bausch Health Co Inc. - Business segments
Exhibit 218: Bausch Health Co Inc. - Key offerings
Exhibit 219: Bausch Health Co Inc. - Segment focus
Exhibit 220: SWOT
Exhibit 221: Biogen Inc. - Overview
Exhibit 222: Biogen Inc. - Product / Service
Exhibit 223: Biogen Inc. - Key news
Exhibit 224: Biogen Inc. - Key offerings
Exhibit 225: SWOT
Exhibit 226: Bristol Myers Squibb Co. - Overview
Exhibit 227: Bristol Myers Squibb Co. - Product / Service
Exhibit 228: Bristol Myers Squibb Co. - Key news
Exhibit 229: Bristol Myers Squibb Co. - Key offerings
Exhibit 230: SWOT
Exhibit 231: Eli Lilly and Co. - Overview
Exhibit 232: Eli Lilly and Co. - Product / Service
Exhibit 233: Eli Lilly and Co. - Key news
Exhibit 234: Eli Lilly and Co. - Key offerings
Exhibit 235: SWOT
Exhibit 236: H. Lundbeck AS - Overview
Exhibit 237: H. Lundbeck AS - Product / Service
Exhibit 238: H. Lundbeck AS - Key offerings
Exhibit 239: SWOT
Exhibit 240: Ionis Pharmaceuticals Inc. - Overview
Exhibit 241: Ionis Pharmaceuticals Inc. - Product / Service
Exhibit 242: Ionis Pharmaceuticals Inc. - Key news
Exhibit 243: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Johnson and Johnson - Overview
Exhibit 246: Johnson and Johnson - Business segments
Exhibit 247: Johnson and Johnson - Key news
Exhibit 248: Johnson and Johnson - Key offerings
Exhibit 249: Johnson and Johnson - Segment focus
Exhibit 250: SWOT
Exhibit 251: Kyowa Kirin Co. Ltd. - Overview
Exhibit 252: Kyowa Kirin Co. Ltd. - Business segments
Exhibit 253: Kyowa Kirin Co. Ltd. - Key offerings
Exhibit 254: Kyowa Kirin Co. Ltd. - Segment focus
Exhibit 255: SWOT
Exhibit 256: Neurocrine Biosciences Inc. - Overview
Exhibit 257: Neurocrine Biosciences Inc. - Product / Service
Exhibit 258: Neurocrine Biosciences Inc. - Key offerings
Exhibit 259: SWOT
Exhibit 260: Novartis AG - Overview
Exhibit 261: Novartis AG - Business segments
Exhibit 262: Novartis AG - Key news
Exhibit 263: Novartis AG - Key offerings
Exhibit 264: Novartis AG - Segment focus
Exhibit 265: SWOT
Exhibit 266: Sun Pharmaceutical Industries - Overview
Exhibit 267: Sun Pharmaceutical Industries - Business segments
Exhibit 268: Sun Pharmaceutical Industries - Key news
Exhibit 269: Sun Pharmaceutical Industries - Key offerings
Exhibit 270: Sun Pharmaceutical Industries - Segment focus
Exhibit 271: SWOT
Exhibit 272: Tasly Pharmaceutical Group Co. - Overview
Exhibit 273: Tasly Pharmaceutical Group Co. - Product / Service
Exhibit 274: Tasly Pharmaceutical Group Co. - Key offerings
Exhibit 275: SWOT
Exhibit 276: Teva Pharmaceutical Ltd. - Overview
Exhibit 277: Teva Pharmaceutical Ltd. - Business segments
Exhibit 278: Teva Pharmaceutical Ltd. - Key news
Exhibit 279: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 280: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Viatris Inc. - Overview
Exhibit 283: Viatris Inc. - Business segments
Exhibit 284: Viatris Inc. - Key news
Exhibit 285: Viatris Inc. - Key offerings
Exhibit 286: Viatris Inc. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Inclusions checklist
Exhibit 289: Exclusions checklist
Exhibit 290: Currency conversion rates for US$
Exhibit 291: Research methodology
Exhibit 292: Information sources
Exhibit 293: Data validation
Exhibit 294: Validation techniques employed for market sizing
Exhibit 295: Data synthesis
Exhibit 296: 360 degree market analysis
Exhibit 297: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Product - Market share 2025-2030 (%)
Exhibit 39: Data Table on Product - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Product
Exhibit 41: Data Table on Comparison by Product
Exhibit 42: Chart on Antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Non-antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Non-antipsychotics - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Non-antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Non-antipsychotics - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 66: Chart on Application - Market share 2025-2030 (%)
Exhibit 67: Data Table on Application - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Application
Exhibit 69: Data Table on Comparison by Application
Exhibit 70: Chart on Children - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Children - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Children - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Children - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Adults - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Adults - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Adults - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Adults - Year-over-year growth 2025-2030 (%)
Exhibit 78: Market opportunity by Application ($ million)
Exhibit 79: Data Table on Market opportunity by Application ($ million)
Exhibit 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 81: Chart on Market share by geography 2025-2030 (%)
Exhibit 82: Data Table on Market share by geography 2025-2030 (%)
Exhibit 83: Chart on Geographic comparison
Exhibit 84: Data Table on Geographic comparison
Exhibit 85: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 88: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 89: Chart on Regional Comparison - North America
Exhibit 90: Data Table on Regional Comparison - North America
Exhibit 91: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 95: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Regional Comparison - Europe
Exhibit 108: Data Table on Regional Comparison - Europe
Exhibit 109: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Regional Comparison - Asia
Exhibit 138: Data Table on Regional Comparison - Asia
Exhibit 139: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 168: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 169: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Market opportunity by geography ($ million)
Exhibit 202: Data Tables on Market opportunity by geography ($ million)
Exhibit 203: Impact of drivers and challenges in 2025 and 2030
Exhibit 204: Overview on criticality of inputs and factors of differentiation
Exhibit 205: Overview on factors of disruption
Exhibit 206: Impact of key risks on business
Exhibit 207: Companies covered
Exhibit 208: Company ranking index
Exhibit 209: Matrix on companies position and classification
Exhibit 210: AstraZeneca Plc - Overview
Exhibit 211: AstraZeneca Plc - Business segments
Exhibit 212: AstraZeneca Plc - Key news
Exhibit 213: AstraZeneca Plc - Key offerings
Exhibit 214: AstraZeneca Plc - Segment focus
Exhibit 215: SWOT
Exhibit 216: Bausch Health Co Inc. - Overview
Exhibit 217: Bausch Health Co Inc. - Business segments
Exhibit 218: Bausch Health Co Inc. - Key offerings
Exhibit 219: Bausch Health Co Inc. - Segment focus
Exhibit 220: SWOT
Exhibit 221: Biogen Inc. - Overview
Exhibit 222: Biogen Inc. - Product / Service
Exhibit 223: Biogen Inc. - Key news
Exhibit 224: Biogen Inc. - Key offerings
Exhibit 225: SWOT
Exhibit 226: Bristol Myers Squibb Co. - Overview
Exhibit 227: Bristol Myers Squibb Co. - Product / Service
Exhibit 228: Bristol Myers Squibb Co. - Key news
Exhibit 229: Bristol Myers Squibb Co. - Key offerings
Exhibit 230: SWOT
Exhibit 231: Eli Lilly and Co. - Overview
Exhibit 232: Eli Lilly and Co. - Product / Service
Exhibit 233: Eli Lilly and Co. - Key news
Exhibit 234: Eli Lilly and Co. - Key offerings
Exhibit 235: SWOT
Exhibit 236: H. Lundbeck AS - Overview
Exhibit 237: H. Lundbeck AS - Product / Service
Exhibit 238: H. Lundbeck AS - Key offerings
Exhibit 239: SWOT
Exhibit 240: Ionis Pharmaceuticals Inc. - Overview
Exhibit 241: Ionis Pharmaceuticals Inc. - Product / Service
Exhibit 242: Ionis Pharmaceuticals Inc. - Key news
Exhibit 243: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Johnson and Johnson - Overview
Exhibit 246: Johnson and Johnson - Business segments
Exhibit 247: Johnson and Johnson - Key news
Exhibit 248: Johnson and Johnson - Key offerings
Exhibit 249: Johnson and Johnson - Segment focus
Exhibit 250: SWOT
Exhibit 251: Kyowa Kirin Co. Ltd. - Overview
Exhibit 252: Kyowa Kirin Co. Ltd. - Business segments
Exhibit 253: Kyowa Kirin Co. Ltd. - Key offerings
Exhibit 254: Kyowa Kirin Co. Ltd. - Segment focus
Exhibit 255: SWOT
Exhibit 256: Neurocrine Biosciences Inc. - Overview
Exhibit 257: Neurocrine Biosciences Inc. - Product / Service
Exhibit 258: Neurocrine Biosciences Inc. - Key offerings
Exhibit 259: SWOT
Exhibit 260: Novartis AG - Overview
Exhibit 261: Novartis AG - Business segments
Exhibit 262: Novartis AG - Key news
Exhibit 263: Novartis AG - Key offerings
Exhibit 264: Novartis AG - Segment focus
Exhibit 265: SWOT
Exhibit 266: Sun Pharmaceutical Industries - Overview
Exhibit 267: Sun Pharmaceutical Industries - Business segments
Exhibit 268: Sun Pharmaceutical Industries - Key news
Exhibit 269: Sun Pharmaceutical Industries - Key offerings
Exhibit 270: Sun Pharmaceutical Industries - Segment focus
Exhibit 271: SWOT
Exhibit 272: Tasly Pharmaceutical Group Co. - Overview
Exhibit 273: Tasly Pharmaceutical Group Co. - Product / Service
Exhibit 274: Tasly Pharmaceutical Group Co. - Key offerings
Exhibit 275: SWOT
Exhibit 276: Teva Pharmaceutical Ltd. - Overview
Exhibit 277: Teva Pharmaceutical Ltd. - Business segments
Exhibit 278: Teva Pharmaceutical Ltd. - Key news
Exhibit 279: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 280: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Viatris Inc. - Overview
Exhibit 283: Viatris Inc. - Business segments
Exhibit 284: Viatris Inc. - Key news
Exhibit 285: Viatris Inc. - Key offerings
Exhibit 286: Viatris Inc. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Inclusions checklist
Exhibit 289: Exclusions checklist
Exhibit 290: Currency conversion rates for US$
Exhibit 291: Research methodology
Exhibit 292: Information sources
Exhibit 293: Data validation
Exhibit 294: Validation techniques employed for market sizing
Exhibit 295: Data synthesis
Exhibit 296: 360 degree market analysis
Exhibit 297: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Bausch Health Co Inc.
- Biogen Inc.
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Co.
- Catalyst Pharmaceuticals Inc.
- Eli Lilly and Co.
- H. Lundbeck AS
- Ionis Pharmaceuticals Inc.
- Johnson and Johnson
- Kyowa Kirin Co. Ltd.
- Neurocrine Biosciences Inc.
- Novartis AG
- Otsuka Pharmaceutical Co Ltd.
- Sun Pharmaceutical Industries
- Synendos Therapeutics AG
- Tasly Pharmaceutical Group Co.
- Teva Pharmaceutical Ltd.
- Viatris Inc.
